A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

Study Summary

The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.

Conditions

Overweight Obesity

Interventions / Drugs

UBT251 Placebo

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment333 participants

Primary Completion—

Lead SponsorNovo Nordisk A/S

Data Retrieved2026-04-11 02:55:47.366601+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.